Warner Chilcott News

Warner Chilcott plc : BofA/Merrill is assuming assuming a sale of Warner Chilcott and said if it does not happen there are other alternatives to drive shares higher.

Warner Chilcott reported Q1 EPS of $1.16, topping estimates of $0.17. Revenues in the quarter fell 9.5% year-over-year to $685 million, missing estimates by $37 million.

On Friday, Warner Chilcott PLC Class A reported its first quarter earnings and discussed the following topics in its earnings conference call.

ONE of Ireland 's richest men stands to win a third multimillion euro fortune from the sale of the drugs company empire he helped build up.

The 10-second takeaway For the quarter ended March 31 , Warner Chilcott beat expectations on revenues and crushed expectations on earnings per share.

Specialty pharmaceutical company Warner Chilcott PLC posted a higher adjusted quarterly profit, but cut its full-year forecast, days after it said it would explore strategic alternatives.

The Ireland-based drugmaker said it now expects an adjusted profit of $3.30 to $3.40 per share for 2012, adjusting for costs from restructuring that began in April.

Warner Chilcott Ltd. this week lost a federal ruling in a patent-infringement suit over a generic version of its antibiotic Doryx, used to treat severe acne.

In a research report released this morning by Bank of America, Warner Chilcott announced that it is exploring a range of strategic alternatives to enhance shareholder value.

Warner Chilcott plc today announced that the U.S. District Court for the District of New Jersey upheld the validity of the U.S. patent covering the Company's DORYX 150 mg product , but determined that neither Mylan Inc.'s nor Impax Pharmaceuticals, Inc.'s proposed generic version of the DORYX 150 mg product infringed the '161 Patent.

The Coca-Cola Company : Stifel believes Monster is an attractive target for Coca-Cola and estimates an $85 per share all cash bid wold be accretive to Coke.

Monster Beverage Corp : UBS believes Coca-Cola could pay between $84 and $100 per share to acquire Monster Worldwide .

From time to time, we will send you e-mail announcements on new features and special offers from The Wall Street Journal Online.

A number of other firms have also recently commented on WCRX. Analysts at Auriga initiated coverage on shares of Warner Chilcott in a research note to investors on Tuesday, April 17th.

Warner Chilcott is evaluating options, including a possible sale of the company, after receiving interest from strategic and private-equity buyers, Bloomberg News reported on Monday.